日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone

辅助药物使用阈值和开始注射纳曲酮的概率

期刊:Addiction
影响因子:5.3
doi:10.1111/add.70189
Rudolph, Kara E; Inose, Shodai; Williams, Nicholas T; Díaz, Iván; Ross, Rachael K; Bisaga, Adam; Shulman, Matisyahu
发表日期：2025
文献求助 收藏

Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial

随机分配至丁丙诺啡或纳曲酮治疗阿片类药物使用障碍对大麻使用结果的影响：X:BOT试验的二次分析

期刊:Drug and Alcohol Dependence
影响因子:3.6
doi:10.1016/j.drugalcdep.2025.112550
Shulman, Matisyahu; Choo, Tse-Hwei; Ohrtman, Kaitlyn; Pavlicova, Martina; Rotrosen, John; Nunes, Edward V
发表日期：2025
文献求助 收藏

Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)

优化阿片类药物使用障碍药物治疗的维持策略：CTN-0100 试验的维持阶段 (RDD)

期刊:Contemporary Clinical Trials
影响因子:1.9
doi:10.1016/j.cct.2025.107816
Shulman, Matisyahu; Meyers-Ohki, Sarah; Novo, Patricia; Provost, Scott; Ohrtman, Kaitlyn; Van Veldhuisen, Paul; Oden, Neal; Otterstatter, Michael; Bailey, Genie L; Liu, David; Rotrosen, John; Weiss, Roger D; Nunes, Edward V
发表日期：2025
文献求助 收藏

A clinical trial loses access to some of its experimental treatment conditions: What can be done?

临床试验失去了一些实验性治疗条件：该怎么办？

期刊:
影响因子:
doi:10.1016/j.josat.2025.209854
Meyers-Ohki, Sarah; Shulman, Matisyahu; Weiss, Roger D; Novo, Patricia; Provost, Scott; Otterstatter, Michael; Bailey, Genie L; Rotrosen, John; Nunes, Edward V
发表日期：2025
文献求助 收藏

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial

快速启动纳曲酮注射治疗阿片类药物使用障碍：一项阶梯楔形整群随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2024.9744
Shulman, Matisyahu; Greiner, Miranda G; Tafessu, Hiwot M; Opara, Onumara; Ohrtman, Kaitlyn; Potter, Kenzie; Hefner, Kathryn; Jelstrom, Eve; Rosenthal, Richard N; Wenzel, Kevin; Fishman, Marc; Rotrosen, John; Ghitza, Udi E; Nunes, Edward V; Bisaga, Adam
发表日期：2024
文献求助 收藏

Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity

临床试验中阿片类激动剂剂量因种族和民族而异

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2024.36612
Ross, Rachael K; Inose, Shodai; Shulman, Matisyahu; Nunes, Edward V; Zalla, Lauren C; Burlew, A Kathleen; Rudolph, Kara E
发表日期：2024
文献求助 收藏

Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

比较缓释纳曲酮和舌下含服丁丙诺啡治疗医疗补助患者阿片类药物使用障碍的疗效

期刊:Addiction
影响因子:5.3
doi:10.1111/add.16630
Ross, Rachael K; Nunes, Edward V; Olfson, Mark; Shulman, Matisyahu; Krawczyk, Noa; Stuart, Elizabeth A; Rudolph, Kara E
发表日期：2024
文献求助 收藏

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

阿片类药物使用障碍药物治疗疗程成功后停止治疗：CTN-0100 (RDD) 试验的停药阶段

期刊:Contemporary Clinical Trials
影响因子:1.9
doi:10.1016/j.cct.2024.107543
Shulman, Matisyahu; Provost, Scott; Ohrtman, Kaitlyn; Novo, Patricia; Meyers-Ohki, Sarah; Van Veldhuisen, Paul; Oden, Neal; Otterstatter, Michael; Bailey, Genie L; Liu, David; Rotrosen, John; Nunes, Edward V; Weiss, Roger D
发表日期：2024
文献求助 收藏

Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

比较缓释纳曲酮和舌下含服丁丙诺啡治疗医疗补助患者阿片类药物使用障碍的疗效

期刊:
影响因子:
doi:10.1101/2024.01.24.24301555
Ross, Rachael K; Nunes, Edward V; Olfson, Mark; Shulman, Matisyahu; Krawczyk, Noa; Stuart, Elizabeth A; Rudolph, Kara E
发表日期：2024
文献求助 收藏

Recent Progress on One-Pot Multisubstrate Screening

一锅法多底物筛选的最新进展

期刊:Organic Process Research & Development
影响因子:3.5
doi:10.1021/acs.oprd.3c00128
Fogel, Matisyahu S; Koide, Kazunori
发表日期：2023
文献求助 收藏